After showing promising results in early-phase trials for ischemic heart disease, stem-cell therapy is now being examined as a possible mechanism to treat congenital diseases such as hyperplastic left heart syndrome. Drs Harold Burkart and Timothy Nelson discuss researchers' efforts to understand the origins of congenital heart diseases and how regenerative therapies might one day fit into this framework.